AWM
WST icon

Accredited Wealth Management’s West Pharmaceutical WST Stock Holding History

Accredited Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$10.5K Buy
270
+230
+575% +$55.9K 0.01% 258
2025
Q2 		$8.75K Buy
40
+15
+60% +$3.21K 0.01% 275
2025
Q1 		$5.6K Buy
+25
New +$6.89K ﹤0.01% 292

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Accredited Wealth Management's WST Position: Q3 2025 in Review

Accredited Wealth Management increased its West Pharmaceutical (WST) stake by 575% in Q3 2025, buying an estimated $55.9K and bringing the position to 270 shares worth $10.5K. The position accounts for 0.01% of the portfolio, ranked #258.

Accredited Wealth Management first reported a position in WST in Q1 2025 and has held it in 3 quarters since. 756 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Accredited Wealth Management held 270 shares of West Pharmaceutical worth $10.5K as of Q3 2025.
  • Accredited Wealth Management bought 230 West Pharmaceutical shares in Q3 2025, an estimated $55.9K.
  • West Pharmaceutical made up 0.01% of Accredited Wealth Management's portfolio in Q3 2025, its #258 holding.
  • Accredited Wealth Management first reported a position in West Pharmaceutical in Q1 2025 and has held it in 3 quarters since.
  • 756 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Accredited Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.